Harte Hanks appoints David Fisher as president to lead transformation

CHELMSFORD, MA - Harte Hanks, Inc. (NASDAQ:HHS), a customer experience company with annual revenue of $181.35 million, announced Monday the appointment of David Fisher as President, as the company advances its transformation initiatives aimed at driving sustained EBITDA growth. According to InvestingPro data, the company faces profitability challenges with negative EBITDA in the last twelve months, though analysts project a return to profitability in 2025.

Fisher, who joined Harte Hanks in March 2023 as a strategic development advisor, was named Chief Transformation Officer in January 2024, where he launched ’Project Elevate,’ a company-wide initiative focused on EBITDA stability and service innovation. He was later appointed Interim Chief Operating Officer in January 2025. The company’s stock has shown recent momentum with a 12.82% gain over the past week, despite being down 23.11% year-to-date. InvestingPro analysis indicates the stock is currently trading below its Fair Value.

"I’m honored to step into this role at such an exciting time for Harte Hanks," Fisher said. "We’re building on a foundation of strong business fundamentals while embracing the power of AI to deliver exceptional client service."

Jack Griffin, Chairman of the Board, stated: "David’s leadership has been nothing short of transformational. He brings a rare combination of strategic vision, operational rigor, and entrepreneurial focus."

In his new role, Fisher will lead day-to-day operations and drive strategic execution in partnership with the company’s executive leadership team. The leadership transition comes as Harte Hanks aims to accelerate growth by deepening services with existing clients, adding new client relationships, and expanding its footprint in key sectors.

Harte Hanks provides customer experience strategy, data-driven analytics, and program execution for clients across various industries. The company employs over 2,000 people in offices throughout the Americas, Europe, and Asia Pacific.

This article is based on a press release statement from Harte Hanks.

In other recent news, Harte Hanks has announced the acquisition of exclusive licensing rights to a significant health data asset from ADS Data Direct. This agreement provides Harte Hanks with control over the Medical Ailment Database, which is expected to enhance its capabilities in healthcare marketing. Additionally, Harte Hanks held its 2025 Annual Meeting of Stockholders, where shareholders approved the election of four board members and endorsed the company’s executive compensation package. The selection of Wolf & Company P.C. as the independent auditor for the fiscal year ending December 31, 2025, was also ratified during the meeting.

In another development, Harte Hanks entered into a cooperation agreement with major shareholders Gary S. Rosenbach and Susan Rosenbach. The agreement includes several standstill provisions and mutual non-disparagement clauses, indicating a collaborative approach to corporate governance. The Rosenbachs have agreed to vote their shares in alignment with the board’s recommendations at shareholder meetings. These recent developments reflect Harte Hanks’ strategic moves in data acquisition and corporate governance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.